Catalent(CTLT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTLT Catalent

交易中 04-10 15:26:31 EDT

63.48

+0.00

0.00%

最高63.48	最低63.48	成交量0.00
今开63.48	昨收63.48	日振幅0.00%
总市值115.22亿	流通市值114.51亿	总股本1.82亿
成交额0.00	换手率0.00%	流通股本1.80亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTLT","market":"US","secType":"STK","nameCN":"Catalent","latestPrice":63.48,"timestamp":1744313191452,"preClose":63.48,"halted":0,"volume":0,"delay":0,"floatShares":180392022,"shares":181511586,"eps":-2.280772,"marketStatus":"交易中","change":0,"latestTime":"04-10 15:26:31 EDT","open":63.48,"high":63.48,"low":63.48,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.280772,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1744315200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1406779200000,"exchange":"NYSE","adjPreClose":63.48,"volumeRatio":0},"requestUrl":"/m/hq/s/CTLT","defaultTab":"news","newsList":[{"id":"2486474895","title":"欧盟或将无条件批准诺和诺德母公司收购Catalent","url":"https://stock-news.laohu8.com/highlight/detail?id=2486474895","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486474895?lang=zh_cn&edition=full","pubTime":"2024-11-25 07:52","pubTimestamp":1732492325,"startTime":"0","endTime":"0","summary":"据报道，欧盟委员会可能将无条件批准诺和诺德母公司Novo Holdings以165亿美元收购美国合同制药商Catalent 的交易。今年2月，Catalent同意以每股63.50美元的价格被Novo Holdings收购。Novo Holdings随后将向诺和诺德出售三个Catalent生产基地，这将有助于诺和诺德提高其畅销减肥药Wegovy的产量。诺和诺德和Catalent最近都重申了它们的预期，即交易将在今年年底前完成。截至周五收盘，Catalent涨2.21%，报60.98美元；诺和诺德涨2.37%，报105.06美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/25075245624283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4585","BK4007","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","CTLT","BK4599","LU1093756325.SGD","LU1093756168.USD","BK4530","NVO","BK4532","LU0154236417.USD"],"gpt_icon":1},{"id":"2485722009","title":"欧盟或将无条件批准诺和诺德(NVO.US)母公司收购Catalent(CTLT.US)","url":"https://stock-news.laohu8.com/highlight/detail?id=2485722009","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2485722009?lang=zh_cn&edition=full","pubTime":"2024-11-23 14:50","pubTimestamp":1732344657,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据报道，欧盟委员会可能将无条件批准诺和诺德 母公司Novo Holdings以165亿美元收购美国合同制药商Catalent的交易。今年2月，Catalent同意以每股63.50美元的价格被Novo Holdings收购。Novo Holdings随后将向诺和诺德出售三个Catalent生产基地，这将有助于诺和诺德提高其畅销减肥药Wegovy的产量。诺和诺德和Catalent最近都重申了它们的预期，即交易将在今年年底前完成。截至周五收盘，Catalent涨2.21%，报60.98美元；诺和诺德涨2.37%，报105.06美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CTLT","IE00BZ1G4Q59.USD","BK4530","LU1093756168.USD","BK4532","BK4599","IE00BKVL7J92.USD","BK4585","BK4007","BK4588","LU1093756325.SGD","LU0154236417.USD","NVO"],"gpt_icon":1},{"id":"2480798573","title":"欧盟将于12月6日前对诺和诺德作出裁决","url":"https://stock-news.laohu8.com/highlight/detail?id=2480798573","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2480798573?lang=zh_cn&edition=full","pubTime":"2024-11-04 16:57","pubTimestamp":1730710637,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，根据欧盟委员会网站周一发布的文件，欧盟反垄断监管机构将在12月6日之前决定是否批准诺和诺德收购美国合同制药商Catalent。文件显示，诺和诺德控股股东于10月31日向欧盟提交了批准该交易的请求。欧盟反垄断监管机构可以在有或没有补救措施的情况下批准这笔交易，也可以在有严重担忧的情况下展开为期4个月的全面调查。此次收购于今年2月宣布，突显了丹麦制药商诺和诺德提高其畅销减肥药Wegovy产量的努力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104170309ab9de4d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"c8930b257377b3ad681bfe33e024f8d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104170309ab9de4d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTLT","IE00BZ1G4Q59.USD","BK4530","LU1093756168.USD","BK4532","IE00BKVL7J92.USD","LLY","BK4585","BK4007","BK4588","LU1093756325.SGD","LU0154236417.USD","NVO"],"gpt_icon":1},{"id":"2476375401","title":"减肥药扩产计划遇阻！美国消费者团体要求FTC阻止诺和诺德","url":"https://stock-news.laohu8.com/highlight/detail?id=2476375401","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2476375401?lang=zh_cn&edition=full","pubTime":"2024-10-18 17:33","pubTimestamp":1729243990,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周四，美国消费者团体和两个大型工会敦促美国联邦贸易委员会阻止诺和诺德股东Novo Holdings收购合同药品制造商Catalent Inc.，称该交易威胁到减肥药和尖端基因疗法领域的竞争。这三座工厂专门从事药品的无菌灌装，预计将从2026年起逐步增加诺和诺德的灌装能力。当地时间周四下午，十个消费者团体签署了这封信。不过，所涉及的Catalent工厂与Novo Holdings计划出售给诺和诺德的三家工厂并不相关。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410181735119f4cecaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410181735119f4cecaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4585","LU1093756168.USD","BK4007","BK4588","FTC","NVO","BK4532","IE00BKVL7J92.USD","BK4530","CTLT","LU0154236417.USD"],"gpt_icon":0},{"id":"2476416906","title":"消费者团体要求美国FTC阻止Novo Holdings收购Catalent的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2476416906","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2476416906?lang=zh_cn&edition=full","pubTime":"2024-10-18 10:35","pubTimestamp":1729218957,"startTime":"0","endTime":"0","summary":"据路透，美国消费者团体和两大工会周四敦促美国联邦贸易委员会(FTC)阻止诺和诺德控股股东Novo Holdings收购合同药物制造商Catalent，称该交易威胁减肥药和尖端基因疗法领域的竞争。美国公共利益研究组织、服务业雇员国际工会(SEIU)和其他组织在一封致FTC的信中表达了对这笔价值165亿美元交易的担忧。上周，美国民主党参议员沃伦呼吁FTC密切关注这笔交易，理由也是类似的担忧。该交易可能会限制安进、辉瑞、罗氏和阿斯利康等竞争对手的选择，据报道，这些竞争对手正在开发GLP-1药物。\n\n\r\n            责任编辑：栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/10/18103544144055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4530","BK4585","FTC","CTLT","BK4007","BK4588"],"gpt_icon":0},{"id":"2475560363","title":"Catalent将出售新泽西工厂","url":"https://stock-news.laohu8.com/highlight/detail?id=2475560363","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2475560363?lang=zh_cn&edition=full","pubTime":"2024-10-14 19:59","pubTimestamp":1728907161,"startTime":"0","endTime":"0","summary":"金吾财讯 | Catalent 已同意将其位于新泽西州萨默塞特的口服药物开发和小规模制造工厂出售给私人合同药品制造商 Ardena。Catalent 为包括丹麦制药巨头诺和诺德的药物 Wegovy 在内的制药商提供合同制造服务并执行灌装工作，涉及注射器和注射笔的无菌灌装和包装。拥有诺和诺德控股权的投资公司 Novo Holdings 于 2 月份签署了一项价值 165 亿美元的协议收购 Catalent，以增加 Wegovy 的供应，预计该交易将于今年年底完成。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"280858","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4532","BK4585","LU0154236417.USD","CTLT","LU1093756168.USD","LU1093756325.SGD","NVO","BK4530","BK4007","IE00BZ1G4Q59.USD","BK4588"],"gpt_icon":0},{"id":"2474173697","title":"美国民主党参议员沃伦敦促联邦贸易委员会调查诺和诺德与Catalent的合并。","url":"https://stock-news.laohu8.com/highlight/detail?id=2474173697","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2474173697?lang=zh_cn&edition=full","pubTime":"2024-10-10 20:22","pubTimestamp":1728562935,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0154236417.USD","BK4530","CTLT","BK4585","BK4588","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","LU1093756325.SGD","BK4007","IE00BKVL7J92.USD","BK4532"],"gpt_icon":0}],"profile":{"websiteUrl":"http://catalent.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.0501},{"period":"1year","weight":0.1135},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0282},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0693},{"period":"6month","weight":-0.0534},{"period":"1year","weight":0.0564},{"period":"ytd","weight":-0.0639}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Catalent, Inc.是全球领先的药物先进递送技术和开发制造解决方案提供商；蛋白质、细胞和基因治疗生物制品以及消费健康产品。该公司的口服、注射、细胞和基因治疗以及细胞和呼吸输送技术解决了制药行业的全面多样性，包括小分子；蛋白质、细胞和基因治疗生物制品；以及消费健康产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.058226},{"month":2,"riseRate":0.6,"avgChangeRate":0.038189},{"month":3,"riseRate":0.4,"avgChangeRate":0.009076},{"month":4,"riseRate":0.6,"avgChangeRate":0.013795},{"month":5,"riseRate":0.5,"avgChangeRate":0.014479},{"month":6,"riseRate":0.6,"avgChangeRate":0.020877},{"month":7,"riseRate":0.8,"avgChangeRate":0.082712},{"month":8,"riseRate":0.636364,"avgChangeRate":0.009563},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.037618},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.028945},{"month":11,"riseRate":0.636364,"avgChangeRate":0.013867},{"month":12,"riseRate":0.545455,"avgChangeRate":0.006017}],"exchange":"NYSE","name":"Catalent","nameEN":"Catalent"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.2","shortVersion":"4.32.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Catalent(CTLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Catalent(CTLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Catalent,CTLT,Catalent股票,Catalent股票老虎,Catalent股票老虎国际,Catalent行情,Catalent股票行情,Catalent股价,Catalent股市,Catalent股票价格,Catalent股票交易,Catalent股票购买,Catalent股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Catalent(CTLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Catalent(CTLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}